Financials
Income statement
Fiscal date | Apr 2025 | Jan 2025 | Oct 2024 | Jul 2024 |
---|---|---|---|---|
Total reported revenue | 13.3B | 18.0B | 15.0B | 15.9B |
Cost of revenue | 5.2B | 8.3B | 5.8B | 6.9B |
Gross profit | 8.1B | 9.7B | 9.2B | 9.0B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | — |
Other operating expenses | 4.2B | -11.4B | 4.5B | 4.7B |
Operating income | 2.6B | 3.2B | 3.4B | 3.1B |
Non operating interest income | ||||
Income | 94.9M | 299.1M | 133.5M | — |
Expense | 90.1M | 302.3M | 88.4M | — |
Other income expense | — | — | — | — |
Pretax income | 2.7B | 2.9B | 3.5B | 3.1B |
Tax provision | 588.6M | 651.3M | 763.9M | 718.8M |
Net income | 2.1B | 2.3B | 2.7B | 2.4B |
Basic EPS | 0.4 | — | — | — |
Diluted EPS | 0.4 | — | — | — |
Basic average shares | 5.0B | — | — | — |
Diluted average shares | 5.0B | — | — | — |
EBITDA | 4.0B | 4.4B | 4.8B | 4.6B |
Net income from continuing op. | — | — | — | — |
Minority interests | 0 | 0 | -3.2M | -6.4M |
Preferred stock dividends | 0 | 0 | 0 | 0 |